Albemarle (NYSE:ALB) Price Target Raised to $185.00

Albemarle (NYSE:ALB) had its price target hoisted by Rothschild & Co Redburn from $158.00 to $185.00 in a report published on Tuesday,MarketScreener reports. They currently have a buy rating on the specialty chemicals company’s stock.

Several other research firms have also recently weighed in on ALB. Morgan Stanley restated an “equal weight” rating on shares of Albemarle in a research note on Friday, December 19th. Bank of America boosted their price objective on shares of Albemarle from $118.00 to $167.00 and gave the stock a “neutral” rating in a research report on Thursday, January 8th. Citigroup increased their target price on shares of Albemarle from $150.00 to $180.00 and gave the company a “neutral” rating in a research report on Tuesday, February 3rd. Oppenheimer boosted their price target on shares of Albemarle from $109.00 to $207.00 and gave the company an “outperform” rating in a research report on Wednesday, January 21st. Finally, BMO Capital Markets raised their price objective on Albemarle from $145.00 to $210.00 and gave the stock an “outperform” rating in a report on Tuesday, January 20th. Three investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $163.40.

Albemarle Price Performance

Albemarle stock opened at $158.47 on Tuesday. The company has a current ratio of 2.27, a quick ratio of 1.51 and a debt-to-equity ratio of 0.40. The company has a fifty day simple moving average of $157.34 and a 200-day simple moving average of $114.39. The stock has a market cap of $18.65 billion, a P/E ratio of -27.56, a price-to-earnings-growth ratio of 2.53 and a beta of 1.44. Albemarle has a 12-month low of $49.43 and a 12-month high of $195.68.

Albemarle (NYSE:ALB) last posted its earnings results on Wednesday, February 11th. The specialty chemicals company reported ($0.53) EPS for the quarter, missing the consensus estimate of ($0.40) by ($0.13). The business had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.34 billion. Albemarle had a negative net margin of 10.74% and a positive return on equity of 0.40%. The business’s quarterly revenue was up 15.9% compared to the same quarter last year. During the same period last year, the company earned ($1.09) EPS. Equities analysts expect that Albemarle will post -0.04 EPS for the current fiscal year.

Hedge Funds Weigh In On Albemarle

Several institutional investors have recently added to or reduced their stakes in ALB. PGGM Investments boosted its holdings in shares of Albemarle by 10.8% in the third quarter. PGGM Investments now owns 1,185,005 shares of the specialty chemicals company’s stock valued at $96,080,000 after acquiring an additional 115,081 shares in the last quarter. Occidental Asset Management LLC purchased a new position in Albemarle in the third quarter worth $3,313,000. CWM LLC lifted its holdings in Albemarle by 14.8% in the third quarter. CWM LLC now owns 165,074 shares of the specialty chemicals company’s stock valued at $13,384,000 after acquiring an additional 21,257 shares during the period. AXQ Capital LP purchased a new stake in shares of Albemarle during the 2nd quarter worth $267,000. Finally, Empower Advisory Group LLC grew its stake in shares of Albemarle by 11.4% during the 2nd quarter. Empower Advisory Group LLC now owns 866,575 shares of the specialty chemicals company’s stock worth $54,308,000 after purchasing an additional 88,457 shares during the period. Institutional investors and hedge funds own 92.87% of the company’s stock.

Trending Headlines about Albemarle

Here are the key news stories impacting Albemarle this week:

• Positive Sentiment: Revenue beat and strong EV/energy-storage demand: Q4 revenue of $1.43B topped estimates and rose ~16% year-over-year, driven by higher Energy Storage volumes and favorable pricing — a sign that lithium end-market demand remains strong. Read More.
• Positive Sentiment: Analyst support and bullish research: Mizuho raised its price target to $185 (neutral rating) and Rothschild/Redburn published a bullish outlook — both actions underpin upside expectations from some sell-side desks. Read More. Read More.
• Positive Sentiment: Policy tailwind for domestic supply: The House passed H.R.3617 (Securing America’s Critical Minerals Supply Act), which aims to strengthen domestic critical-minerals supply chains — a structural tailwind for lithium producers like Albemarle. Read More.
• Neutral Sentiment: FY2026 revenue guidance lifted/updated: Albemarle provided a FY2026 revenue range of roughly $5.7B–$6.0B, above consensus — this signals management expects continued top-line resilience even if EPS guidance was unclear in early releases. Read More.
• Neutral Sentiment: Idling Kemerton Train 1 to preserve flexibility: Management moved Kemerton Train 1 to care & maintenance to improve financial flexibility and optimize global hydroxide mix — reduces near-term operating exposure but keeps restart optionality. Market sees this as prudent capacity management rather than a structural problem. Read More.
• Negative Sentiment: EPS miss and wider-than-expected quarterly loss: Albemarle reported Q4 EPS of ($0.53) vs. consensus ($0.40), which disappointed investors and weighed on near-term sentiment despite the revenue beat. Read More.
• Negative Sentiment: Immediate market reaction and technical pressure: Coverage and market commentary note the stock fell after earnings as traders booked gains and digested the EPS miss; technical indicators show short‑term momentum fatigue, adding to selling pressure. Read More. Read More.

About Albemarle

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.